Complement activation on degraded polyethylene glycol-covered surface

Acta Biomaterialia

Volumn 6, Issue 7, 2010, Pages 2642-2649

  Toda, Mitsuaki ^a,b   Arima, Yusuke ^a   Iwata, Hiroo ^b  

^a Research Institute of Kyoto   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Complement activation; Polyethylene oxide; Protein adsorption; Surface analysis; Surface modification

Indexed keywords

ACTIVATION ANALYSIS; ADSORPTION; CHEMICAL ACTIVATION; IRRADIATION; LUNAR SURFACE ANALYSIS; POLYETHYLENE GLYCOLS; POLYETHYLENES; PROTEINS; SURFACE ANALYSIS; SURFACE TREATMENT;

AMBIENT LIGHT; COMPLEMENT ACTIVATIONS; COMPLEMENT SYSTEMS; GOLD SURFACES; METHOXY; MODIFIED SURFACES; PROTEIN ADSORPTION; REFLECTION ADSORPTION; SURFACE-MODIFICATION; ULTRAVIOLET IRRADIATIONS;

POLYETHYLENE OXIDES;

BIOMATERIAL; MACROGOL; MACROGOL DERIVATIVE;

ADSORPTION; ARTICLE; BLOOD SAMPLING; CHEMICAL MODIFICATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEGRADATION; HUMAN; INFRARED SPECTROSCOPY; LIGHT; PRIORITY JOURNAL; SURFACE PROPERTY; ULTRAVIOLET RADIATION; X RAY PHOTOELECTRON SPECTROSCOPY; CHEMISTRY;

COMPLEMENT ACTIVATION; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES;

EID: 77955917251     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.035     Document Type: Article

References (30)

1. Harris JM. Poly (ethylene glycol) chemistry: biotechnical and biomedical applications. New York: Plenum Press; 1992.
2. Kingshott P, Griesser HJ. Surfaces that resist bioadhesion. Curr Opin Solid State Mater Sci 1999;4:403-12.
3. Nucci ML, Shorr R, Abuchowski A. The therapeutic value of poly (ethylene glycol)-modified proteins. Adv Drug Deliv Rev 1991;6:133-51.
4. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003;2:214-21.
5. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347-60.
6. Uziely B, Jeffers S, Isacson R, Kutsch K, Wei-Tsao D, Yehoshua Z, Libson E, et al. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 1995;13:1777-85.
7. De Marie S. Liposomal and lipid-based formulations of amphotericin B. Leukemia 1996;10:93-6.
8. Alberts DS, Garcia DJ. Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 1997;54:30-5.
9. Skubitz KM, Skubitz APN. Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil (TM)). AntiCancer Drugs 1998;9:45-50.
10. Laverman P, Brouwers AH, Dams ETM, Oyen WJG, Storm G, Van Rooijen N, Corstens FHM, et al. Preclinical and clinical evidence for disappearance of longcirculating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther 2000;293:996-1001.
11. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003;42:463-78.
12. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-66.
13. Arima Y, Toda M, Iwata H. Complement activation on surfaces modified with ethylene glycol units. Biomaterials 2008;29:551-60.
14. Andersson J, Ekdahl KN, Lambris JD, Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005;26:1477-85.
15. Tengvall P, Askendal A, Lundström I. Complement activation by 3-mercapto-1, 2-propanediol immobilized on gold surfaces. Biomaterials 1996;17:1001-7.
16. Whaley K, North J. Haemolytic assays for whole complement activity and individual components. In: Sim RB, Dodds AW, editors. Complement. Walton Street, Oxford: Oxford University Press; 1997.
17. Toda M, Kitazawa T, Hirata I, Hirano Y, Iwata H. Complement activation on surfaces carrying amino groups. Biomaterials 2008;29:407-17.
18. Hirata I, Morimoto Y, Murakami Y, Iwata H, Kitano E, Kitamura H, et al. Study of complement activation on well-defined surfaces using surface plasmon resonance. Colloids Surf B Biointerfaces 2000;18:285-92.
19. Azzam RMA, Bashara NM. Reflection and transmission of polarized light by stratified planar structures. In: Ellipsometry and Polarized Light. Amsterdam: Elsevier; 1987. p. 269-363.
20. Knoll W. Polymer thin films and interfaces characterized with evanescent light. Makromol Chem 1991;192:2827-56.
21. R Development Core Team. R: A Language And Environment For Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009. ISBN 3-900051-07-0. Available from http://www.R-project.org.
22. Pangburn MK. Alternative pathway: activation and regulation. In: Rother K, Till GO, Hänsch GM, editors. The complement system. Second revised edition. Berlin: Springer-Verlag; 1998. p. 93-115.
23. Lhotta K, Wurzner R, Kronenberg F, Oppermann M, Konig P. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 1998;53:1044-51.
24. Nilsson UR. Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol Immunol 2001;38:151-60.
25. Tengvall P, Askendal A, Lundström I. Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro. Biomaterials 1998;19:935-40.
26. Ishida T, Ichihara M, Wang XY, Yamamoto K, Kimura J, Majima E, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 2006;112:15-25.
27. Wang XY, Ishida T, Kiwada H. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J Control Release 2007;119:236-44.
28. Ishida T, Ichihara M, Wang XY, Kiwada H. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 2006;115:243-50.
29. 13C NMR study of the products and mechanism of the thermal oxidative degradation of poly (ethylene oxide). Macromol Chem Phys 2002;203:2273-80.
30. Morlat S, Gardette J-L. Phototransformation of water-soluble polymers. I: photo-and thermooxidation of poly (ethylene oxide) in solid state. Polymer 2001;42:6071-9.